Status: Recruiting
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
The study is a Phase I/II, single-arm, open-label clinical trial, and its primary objective of phase I and phase II is to evaluate the safety and efficacy of U16 Injection in the treatment of relapsed or refractory NHL,respectively.
Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: Sep 21, 2023Locations: 2
Eligibility criteria
Patients who are willing to sign the informed consent form and have good complia... [+13]
Patients with other malignant tumors, except for disease-free survival for more... [+18]